{"altmetric_id":2339611,"counts":{"readers":{"mendeley":14,"citeulike":0,"connotea":0},"blogs":{"unique_users_count":1,"unique_users":[53574],"posts_count":1},"total":{"posts_count":5},"twitter":{"unique_users_count":4,"unique_users":["Neovit_org","educasida","AntibioticResis","BioTerp"],"posts_count":4}},"selected_quotes":["Nucleoside\/nucleotide analog inhibitors of HBV polymerase: MoA and resistance"],"citation":{"abstract":"Hepatitis B virus (HBV) polymerase and human immunodeficiency virus (HIV) reverse transcriptase are structurally related. However, the HBV enzyme has a protein priming activity absent in the HIV enzyme. Approved nucleoside\/nucleotide inhibitors of the HBV polymerase include lamivudine, adefovir, telbivudine, entecavir and tenofovir. Although most of them target DNA elongation, guanosine and adenosine analogs (e.g. entecavir and tenofovir, respectively) also impair protein priming. Major mutational patterns conferring nucleoside\/nucleotide analog resistance include the combinations rtL180M\/rtM204(I\/V) (for lamivudine, entecavir, telbivudine and clevudine) and rtA181V\/rtN236T (for adefovir and tenofovir). However, development of drug resistance is very slow for entecavir and tenofovir. Novel nucleoside\/nucleotide analogs in advanced clinical trials include phosphonates similar to adefovir or tenofovir, and new tenofovir derivatives with improved pharmacological properties.","abstract_source":"pubmed","altmetric_jid":"4f6fa6143cf058f610007078","authors":["Men\u00e9ndez-Arias L","Alvarez M","Pacheco B"],"doi":"10.1016\/j.coviro.2014.04.005","first_seen_on":"2014-05-09T18:36:04+00:00","issns":["18796257"],"journal":"Current Opinion in Virology","last_mentioned_on":1433930494,"links":["http:\/\/www.sciencedirect.com\/science\/article\/pii\/S187962571400087X","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24814823","http:\/\/www.ncbi.nlm.nih.gov\/pubmed\/24814823?dopt=Abstract&utm_source=dlvr.it&utm_medium=twitter"],"pmid":"24814823","pubdate":"2014-05-07T23:00:00+00:00","publisher":"Elsevier","title":"Nucleoside\/nucleotide analog inhibitors of hepatitis B virus polymerase: mechanism of action and resistance.","type":"article","volume":"8C","mendeley_url":"http:\/\/www.mendeley.com\/research\/nucleosidenucleotide-analog-inhibitors-hepatitis-b-virus-polymerase-mechanism-action-resistance"},"altmetric_score":{"score":9.608,"score_history":{"1y":0,"6m":0,"3m":0,"1m":0,"1w":0,"6d":0,"5d":0,"4d":0,"3d":0,"2d":0,"1d":0,"at":9.608},"context_for_score":{"all":{"total_number_of_other_articles":5214302,"mean":6.1509615961972,"rank":544471,"this_scored_higher_than_pct":89,"this_scored_higher_than":4669929,"rank_type":"exact","sample_size":5214302,"percentile":89},"similar_age_3m":{"total_number_of_other_articles":128001,"mean":7.9715170468751,"rank":16926,"this_scored_higher_than_pct":86,"this_scored_higher_than":111074,"rank_type":"exact","sample_size":128001,"percentile":86},"this_journal":{"total_number_of_other_articles":300,"mean":2.2105752508361,"rank":14,"this_scored_higher_than_pct":95,"this_scored_higher_than":286,"rank_type":"exact","sample_size":300,"percentile":95},"similar_age_this_journal_3m":{"total_number_of_other_articles":14,"mean":1.316,"rank":1,"this_scored_higher_than_pct":92,"this_scored_higher_than":13,"rank_type":"exact","sample_size":14,"percentile":92}}},"demographics":{"poster_types":{"member_of_the_public":4},"users":{"twitter":{"cohorts":{"Members of the public":4}},"mendeley":{"by_status":{"Researcher":1,"Student  > Ph. D. Student":3,"Student  > Master":2},"by_discipline":{"Chemistry":1,"Agricultural and Biological Sciences":4,"Biochemistry, Genetics and Molecular Biology":1}}},"geo":{"twitter":{"CA":1,"GB":1,"US":1},"mendeley":{"CO":2}}},"posts":{"twitter":[{"url":"http:\/\/twitter.com\/Neovit_org\/status\/464836631779094529","license":"datasift","rt":["BioTerp"],"citation_ids":[2339611],"posted_on":"2014-05-09T18:37:43+00:00","author":{"name":"Neovit.org","url":"http:\/\/neovit.org","image":"http:\/\/pbs.twimg.com\/profile_images\/453752626010533889\/Sr8TqQFI_normal.png","description":"Highly effective agent for #cancer #immunotherapy,\r\n#destroys #cancerous #tumors and absolutely #non-toxic. \r\nSupport our #indiegogo at https:\/\/t.co\/Ywv75x5Iyi","id_on_source":"Neovit_org","tweeter_id":"2434899253","geo":{"lt":"43.6529206","ln":"-79.3849008","country":"CA"},"followers":356},"tweet_id":"464836631779094529"},{"url":"http:\/\/twitter.com\/educasida\/status\/468461922212265985","license":"datasift","citation_ids":[2339611],"posted_on":"2014-05-19T18:43:20+00:00","author":{"name":"Educasida","url":"http:\/\/educasida.es","image":"https:\/\/pbs.twimg.com\/profile_images\/2749437582\/85ccf1368cea6a62629c84d6455f6e14_normal.png","description":"La web de informaci\u00f3n general sobre el SIDA, consultas y sobretodo dirigida a profesionales en medicina.","id_on_source":"educasida","tweeter_id":"828884130","geo":{"lt":null,"ln":null},"followers":421},"tweet_id":"468461922212265985"},{"url":"https:\/\/twitter.com\/AntibioticResis\/status\/608574720594739200","license":"datasift","citation_ids":[2339611],"posted_on":"2015-06-10T10:01:34+00:00","author":{"name":"AntibioticResistance","image":"https:\/\/pbs.twimg.com\/profile_images\/551766191962746880\/GlO2QteM_normal.jpeg","description":"Keep abreast of the latest developments in the fight against Antibiotic Resistance #AMR with the latest publications curated from PubMed. Run by @mccarthy_ronan","id_on_source":"AntibioticResis","tweeter_id":"2959295439","geo":{"lt":51.50853,"ln":-0.12574,"country":"GB"},"followers":5947},"tweet_id":"608574720594739200"},{"url":"http:\/\/twitter.com\/BioTerp\/status\/464836175312982016","license":"datasift","citation_ids":[2339611],"posted_on":"2014-05-09T18:35:55+00:00","author":{"name":"Zack","url":"http:\/\/www.bioterppartners.com\/","image":"https:\/\/pbs.twimg.com\/profile_images\/551103762165534720\/TRObsfII_normal.png","description":"B.S. Bioengineering | Co-Founder of Bioterp Partners | https:\/\/www.linkedin.com\/pub\/zachary-fink\/82\/b16\/42 | bioterp@outlook.com","id_on_source":"BioTerp","tweeter_id":"1645717729","geo":{"lt":38.97039,"ln":-76.94192,"country":"US"},"followers":3472},"tweet_id":"464836175312982016"}],"blogs":[{"title":"The latest on hepatitis \u2013 with free research for #WorldHepatitisDay","url":"http:\/\/www.elsevier.com\/connect\/the-latest-on-hepatitis-with-free-research-for-world-hepatitis-day","citation_ids":[2386557,2540558,2522862,2540559,2540560,2339611,2536561,2540561,2540562,2540563,2540564,2540565,2540566],"posted_on":"2014-07-25T15:17:00+00:00","summary":"A virtual special issue &ndash; and a Q&amp;A with Dr. Peter Sarnow &ndash; shed light on new research to combat this &ldquo;silent killer&rdquo;","author":{"name":"Elsevier Connect","url":"http:\/\/elsevierconnect.com","description":""}}]}}